Lacosamide Tablet, Film Coated
Product Images NDC 29300-365

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 29300-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 01)

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 01)
Chemical structure of lacosamide, showing the arrangement of its molecular components including methyl, amide, and phenyl groups.*
FDA Label Image

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 02)

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 02)
A bar chart showing median percent reduction in seizure frequency per 28 days from baseline to maintenance phase by dose for three studies. It compares placebo and various doses of Lacosamide, indicating higher median seizure reduction percentages with Lacosamide across Study 2, Study 3, and Study 4.*
FDA Label Image

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 03)

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 03)
A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4.' The x-axis represents the percent of patients (from 100% to 0%), and the y-axis shows the responder rate (equal to or greater improvement to worsening, from -100% to 100%). Four lines depict responder rates for placebo, lacosamide 200 mg/day, lacosamide 300 mg/day, and lacosamide 600 mg/day groups, illustrating comparative patient response rates in clinical studies.*
FDA Label Image

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 04)

FDA Label Image

Lacosamide Tablets, Usp 50 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 05)

Lacosamide Tablets, Usp 50 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 05)
Label for Lacosamide Tablets, USP 50 mg oral film-coated tablets by Unichem Pharmaceuticals (USA), Inc. The label shows the NDC 29300-364-16, packaging of 60 tablets, and manufacturing information for Unichem Laboratories Ltd., India, and Unichem Pharmaceuticals (USA), Inc. It includes storage instructions (20° to 25°C) and cautions to keep drugs out of children's reach.*
FDA Label Image

Lacosamide Tablets, Usp 100 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 06)

Lacosamide Tablets, Usp 100 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 06)
Lacosamide 100 mg film-coated tablets label with NDC 29300-365-16. The label shows storage instructions, dosage information, and warnings to keep the drug out of reach of children. It includes a barcode and indicates the package contains 60 tablets. Manufactured by Unichem Laboratories Ltd., India, and labeled for Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Lacosamide Tablets, Usp 150 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 07)

Lacosamide Tablets, Usp 150 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 07)
Label for Lacosamide Tablets, USP 150 mg, film-coated oral tablets. The label specifies prescription use with 60 tablets per package and instructs pharmacists to dispense the accompanying Medication Guide. Manufactured by Unichem Laboratories Ltd., India, and labeled by Unichem Pharmaceuticals (USA), Inc. Storage instructions and a barcode are also shown.*
FDA Label Image

Lacosamide Tablets, Usp 200 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 08)

Lacosamide Tablets, Usp 200 mg (78b85e15 171b 4c93 8ea4 9978950bb0e6 08)
Lacosamide Tablets, USP 200 mg film-coated tablets label showing the product name, strength, dosage form, and NDC 29300-367-16. The label includes storage instructions at 20° to 25°C and states the product contains 60 tablets. Manufactured by Unichem Laboratories Ltd and labeled for Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 201 1)

Image (78b85e15 171b 4c93 8ea4 9978950bb0e6 201 1)
A Kaplan-Meier survival curve graph comparing the percentage of subjects remaining over time (days) between two groups: Lacosamide and placebo. The graph shows survival probabilities on the vertical axis and time in days on the horizontal axis. The legend identifies lines for placebo (n=121) and Lacosamide (n=118), with statistical data including p-value, hazard ratio, and confidence interval displayed on the graph.*
FDA Label Image

Image (C7228e98 2b0f 4085 970c 4a4b4443516a 151 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.